Oesophagectomy for early adenocarcinoma and dysplasia arising in Barrett's oesophagus
- PMID: 12608973
- DOI: 10.1046/j.1445-2197.2003.02646.x
Oesophagectomy for early adenocarcinoma and dysplasia arising in Barrett's oesophagus
Abstract
Background: Oesophagectomy for high-grade dysplasia is controversial.
Methods: A prospective study was carried out on all patients who presented between 1993 and 2001 with dysplasia or early adeno-carcinoma who were considered fit for surgery. Details of endoscopic biopsies, appearance, surveillance, operative pathology and outcome were recorded.
Results: Of 18 patients, one had low-grade dysplasia, six had high-grade dysplasia and 11 had early adenocarcinoma. No patient had their biopsy diagnosis down-staged following final pathology, but two patients with high-grade dysplasia on biopsy were upstaged to adenocarcinoma. Our only death from disease occurred in a 39-year-old man who had undergone yearly surveillance for 86 months until adenocarcinoma was confirmed. There was no operative mortality.
Conclusion: Oesophagectomy for early adenocarcinoma and dysplasia in Barrett's oesophagus can be done with acceptable rates of mortality and morbidity. Surveillance until adenocarcinoma is confirmed does not guarantee curable disease.
Similar articles
-
Jumbo biopsy forceps protocol still misses unsuspected cancer in Barrett's esophagus with high-grade dysplasia.Gastrointest Endosc. 1999 Feb;49(2):170-6. doi: 10.1016/s0016-5107(99)70482-7. Gastrointest Endosc. 1999. PMID: 9925694 Clinical Trial.
-
The rationale for esophagectomy as the optimal therapy for Barrett's esophagus with high-grade dysplasia.Ann Surg. 1996 May;223(5):585-9; discussion 589-91. doi: 10.1097/00000658-199605000-00014. Ann Surg. 1996. PMID: 8651749 Free PMC article.
-
Oesophagectomy remains the gold standard for treatment of high-grade dysplasia in Barrett's oesophagus.Eur J Cardiothorac Surg. 2005 Nov;28(5):763-6. doi: 10.1016/j.ejcts.2005.08.018. Epub 2005 Sep 26. Eur J Cardiothorac Surg. 2005. PMID: 16188449
-
Malignant Barrett's oesophagus.Eur J Cancer Prev. 1993 Jan;2(1):47-52. doi: 10.1097/00008469-199301000-00008. Eur J Cancer Prev. 1993. PMID: 8428176 Review.
-
Treatment of Barrett's esophagus with high-grade dysplasia.Expert Rev Anticancer Ther. 2009 Mar;9(3):303-16. doi: 10.1586/14737140.9.3.303. Expert Rev Anticancer Ther. 2009. PMID: 19275509 Review.
Cited by
-
The risk of lymph-node metastases in patients with high-grade dysplasia or intramucosal carcinoma in Barrett's esophagus: a systematic review.Am J Gastroenterol. 2012 Jun;107(6):850-62; quiz 863. doi: 10.1038/ajg.2012.78. Am J Gastroenterol. 2012. PMID: 22488081 Free PMC article.
-
High-resolution imaging in Barrett's esophagus: a novel, low-cost endoscopic microscope.Gastrointest Endosc. 2008 Oct;68(4):737-44. doi: 10.1016/j.gie.2008.05.018. Gastrointest Endosc. 2008. PMID: 18926182 Free PMC article.
-
Accuracy and interrater reliability for the diagnosis of Barrett's neoplasia among users of a novel, portable high-resolution microendoscope.Dis Esophagus. 2014 Jan;27(1):55-62. doi: 10.1111/dote.12040. Epub 2013 Feb 26. Dis Esophagus. 2014. PMID: 23442220 Free PMC article.
-
Minimally invasive esophagectomy for dysplastic Barrett's esophagus.World J Surg. 2015 Mar;39(3):608-14. doi: 10.1007/s00268-014-2746-1. World J Surg. 2015. PMID: 25145822 Review.
-
American Gastroenterological Association technical review on the management of Barrett's esophagus.Gastroenterology. 2011 Mar;140(3):e18-52; quiz e13. doi: 10.1053/j.gastro.2011.01.031. Gastroenterology. 2011. PMID: 21376939 Free PMC article. Review. No abstract available.
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Medical